|
Indian Pediatr 2014;51: 637-640 |
 |
Predictors of Mortality in Neonates with
Meconium Aspiration Syndrome
|
Deepak Louis, Venkataseshan Sundaram, Kanya
Mukhopadhyay, Sourabh Dutta and Praveen Kumar
From the Newborn Unit, Department of Pediatrics,
Postgraduate Institute of Medical Education and Research, Chandigarh,
India.
Correspondence to: Dr Venkataseshan Sundaram,
Assistant Professor, Newborn Unit, Department of Pediatrics, PGIMER,
Chandigarh 160 012, India.
Email: [email protected]
Received: January 24, 2014;
Initial review: February 28, 2014;
Accepted: May 12, 2014.
|
Objective: To identify risk
factors for mortality in neonates with meconium aspiration syndrome.
Methods: All neonates (2004-2010) with meconium aspiration syndrome,
irrespective of gestation were included. Risk factors were compared
between those who died and survived. Results: Out of 172 included
neonates, 44 (26%) died. Mean (SD) gestation and birth weight were 37.9
(2.3) weeks and 2545 (646g), respectively. Myocardial dysfunction [aOR
28.4; 95% CI (8.0-101); P<0.001] and higher initial oxygen
requirement [aOR 1.04; 95% CI (1.02-1.07); P<0.001] increased
odds of dying while a higher birth weight [aOR 0.998; 95% CI
(0.997-1.00); P=0.005] reduced the odds of dying. Conclusions:
Meconium aspiration syndrome is associated with significant mortality.
Myocardial dysfunction, birth weight, and initial oxygen requirement are
independent predictors of mortality.
Keywords: Mortality, Neonate, Outcome,
Prognosis, Risk factors.
|
T he most important consequence for a neonate born
through meconium stained liquor (MSL) is Meconium aspiration syndrome
(MAS), that occurs in 1-3% of live births [1,2]. It is an important
cause of neonatal morbidity and mortality in otherwise healthy term and
post-term infants, with a case fatality rate approaching 40% [3]. Only a
few studies from developing countries have looked at the clinical
profile of MAS, associated morbidities and predictors of mortality
[4-6]. In this study, we aimed to evaluate the morbidity profile of
neonates with MAS, and identify the risk factors that predict mortality
during hospital stay in such neonates.
Methods
This case-control study was conducted in a level III
neonatal unit in Northern India. All inborn babies, irrespective of
their gestational age and birth weight, with a diagnosis of MAS born
between January 2004 and December 2010 were included. MAS was
diagnosed when the neonate had respiratory distress in the presence of
MSL with onset within first 24 hours of life, and a chest X-ray
showed non-homogenous infiltrates with or without hyperinflation.
Babies born through MSL were managed as per NRP
guidelines as modified from time to time [7]. Pediatric
residents/neonatology trainees attended all deliveries with MSL and
performed endotracheal suction if indicated. Babies who had significant
respiratory distress were started on non-invasive ventilation, Continuous
Positive Airway Pressue (CPAP) or Non-invasive Mechanical Ventilation
(NIMV), and mechanically ventilated whenever indicated. Inhaled nitric
oxide was available only in the later part of the study period. Case
records of the patients were retrieved. Ante-partum and intra-partum
risk factors were recorded. Chorio-amnionitis was defined as
intra-partum maternal fever of ≥37.8 0C
with at least two of the four: fetal tachycardia (>180/min), uterine
tenderness, maternal leucocyte count >15,000/mm3
and foul smelling vaginal discharge. Risk factors were compared among
survivors and those who died.
For the purpose of the study, Persistent pulmonary
hypertension of newborn (PPHN) was defined on the basis of labile oxygen
saturation, a pre-and post-ductal oxygen saturation difference of >10%
or pre-and postductal partial pressure of arterial oxygen (PaO 2)
difference of >20 mmHg with or without the presence of echocardiographic
evidence of PPHN. Diagnosis of PPHN on echocardiogram was based on the
peak velocity of a tricuspid regurgitant jet with a peak pulmonary
pressure gradient of >20 mmHg [8,9]. Hypotensive shock was defined as
presence of low pulse volume, tachycardia, skin mottling and a capillary
refill time >3 seconds along with a systolic blood pressure (BP) and/or
a diastolic BP <5th centile
[10]. A diagnosis of hypoxic ischemic encephalopathy (HIE) was made
based on Sarnat and Sarnat staging in babies
≥36 weeks of
gestation and Levenes staging in babies <36 weeks [11,12]. Myocardial
dysfunction was diagnosed on the basis of edema, third space fluid
collection, hepatomegaly, S3
gallop or cardiogenic shock, manifesting with capillary filling time
(CFT) >3 seconds or low BP along with elevated Creatinine Phosphokinase
Muscle Brain (CPK-MB >75 IU/L). Renal dysfunction was defined as an
elevated blood urea (>60 mg/dL) or serum creatinine (>1 mg/dL) in the
presence of normal maternal renal function.
Data were entered in to SPSS software version 15
(SPSS Inc., Chicago, IL, USA). Categorical variables were compared using
Chi-square test or Fisher Exact test. Numerical variables were tested
for normality using the Kolmogorov Smirnov test. Normally distributed
numerical variables were compared using the Student-t test and those
with a skewed distribution were compared using the Mann-Whitney U test.
A univariate analysis followed by a multivariable logistic regression
model (forward, step-wise) was done to identify factors that were
significantly associated with mortality. Variables to be entered in the
model were chosen primarily based on a biologically plausible
association between the predictor and response variable; a correlation
matrix was drawn to identify a strong prior relation between the
variables; 1 variable was entered in the model for every 10 subjects
with the outcome of interest. A P value of <0.05 was considered
significant. The predictive ability of the model as a whole was
calculated both by the conventional manner as well as using the
concordance c statistic.
Results
One hundred and seventy neonates were diagnosed to
have MAS during the study period and 44 (26%) of them died. Sixty (35%)
neonates were mechanically ventilated; it was the initial mode in 42
(25%). Non-invasive ventilation was used in 44 (26%) neonates in 24
(14%) as the primary mode, and in 20 (12%) as a weaning mode. Median age
at onset of respiratory distress was 0 hour (IQR, 0 to 1 hour). The
median durations of ventilation and oxygen supplementation were was 22
hours and 66 hours, respectively. Four out of 170 (2.3%) patients
received surfactant therapy for MAS. The median duration of hospital
stay among those who survived was 168 hours and the median time to
mortality was 24 hours.
PPHN, hypotensive shock, HIE (all grades) and
myocardial dysfunction was observed in 29 (17%), 37 (22%), 79 (46%) and
37 (22%) neonates, respectively. Inhaled nitric oxide was used for PPHN
in one patient whereas sildenafil was used in 3 patients. HIE was mild
in 25 (32%), moderate in 44 (56%) and severe in 10 (12%) neonates.
Myocardial dysfunction manifested as cardiogenic shock in 31 (18%)
neonates, tricuspid regurgitation murmur in 1 (0.6%) and only with
elevated CPK-MB levels in the remaining 5 (3%). Pneumothorax was
detected in 7 neonates (4%) while one baby (0.6%) had pneumomediastinum.
TABLE I Comparison of Risk Factors Between Neonates Who Died vs. Survivors
Risk factor |
Died (n=44) |
Survived (n=126) |
Odds ratio or MD (95% CI) |
P value |
Gestation * (wk)
|
37.6 (2.5) |
37.9 (2.2) |
0.3 (-0.451.1) |
0.45 |
Preterm (<37 wk) |
12 (27) |
25 (20) |
1.7 (0.83.9) |
0.17 |
Birth weight (g)* |
2270 (500) |
2641 (664) |
371 (154588) |
0.001 |
Low birth weight (<2500g) |
29 (67) |
48 (38) |
3.1 (1.56.5) |
0.002 |
Females |
24 (55) |
45 (36) |
2.2 (1.14.3) |
0.02 |
Small for gestational age
|
20 (45) |
34 (27) |
2.3 (1.14.6) |
0.02 |
Thick MSL (n=168) |
36 (82) |
98 (78) |
1.2 (0.52.9) |
0.6 |
Caesarean section |
25 (57) |
64 (51) |
1.3 (0.62.5) |
0.49 |
Non-vigorous at birth |
39 (88) |
87 (69) |
3.5 (1.39.5) |
0.01 |
Cord pH* |
7.02 (0.2) |
7.15 (0.1) |
0.13 (0.050.2) |
0.001 |
Apgar score at 1 min# |
3 (1, 5) |
5 (3, 7) |
1.9 (1.12.7) |
<0.001 |
Apgar score at 5 min# |
6 (3, 8) |
8 (7, 9) |
1.9 (1.22.5) |
<0.001 |
Age of onset of resp. distress (h) # |
0 (0, 0) |
0 (0, 1) |
0.9 (-0.62.4) |
0.23 |
Need for mechanical ventilation |
33 (75) |
27 (21) |
11 (4.924.6) |
<0.001 |
Initial oxygen requirement * (%)
|
88 (19) |
57 (23) |
-31.1 (-39 -23) |
<0.001 |
Maximum oxygen requirement * (%) |
95 (14) |
62 (24) |
-32.6 (-4 -24) |
<0.001 |
Duration of ventilation (h)# |
17 (10, 38) |
52 (24, 84) |
0.9 (-17.7 19.6) |
0.92 |
Duration of oxygen supplementation (h)# |
25 (10, 53) |
72 (36, 120) |
72.2 (19.0125.4) |
0.008 |
Initial PaO2 (mm Hg)# |
50 (43, 83) |
60 (48, 104) |
15.3 (-7.2 37.8) |
0.18 |
Persistent pulmonary hypertension
|
17(39) |
12 (10) |
7.6 (3.218.3) |
<0.001 |
Air leak |
4 (9) |
4 (3) |
3.1 (0.712.8) |
0.13 |
Hypotensive shock |
30 (68) |
7 (6) |
36.4 (13.598.2) |
<0.001 |
Hypoxic ischemic encephalopathy |
33 (75) |
46 (37) |
5.2 (2.411.3) |
<0.001 |
Seizure |
11 (25) |
15 (12) |
2.5 (1.05.9) |
0.04 |
Myocardial dysfunction |
29 (66) |
8 (6) |
31.6 (12.182.2) |
<0.001 |
Renal dysfunction |
9 (20) |
8 (6) |
3.9 (1.410.9) |
0.006 |
MSL: meconium stained liquor; MD: mean difference; Values of
*mean (SD); #median (IQR); rest all expressed as n
(%). |
Risk factors of mortality are presented in
Table I. Of the 18 putative risk factors that emerged
significant in univariate analysis, 5 factors namely birth weight (in
grams unit), Apgar score at 5 minute (in a scale of 1 to 10), initial
oxygen requirement (FiO2 in % unit), and need for mechanical
ventilation, and myocardial dysfunction were entered into the regression
model. Myocardial dysfunction was chosen over presence of shock as both
these variables had a high degree of correlation between them on a
correlation matrix and based on a biological assumption that myocardial
dysfunction would have preceded shock. The prediction model identified
that presence of myocardial dysfunction and a higher initial oxygen
requirement increased the odds of death whereas a higher birth weight
reduced the odds of death in these neonates with every 1% increase in
initial O 2 requirement
increasing the odds of death by 4.4% in comparison to baseline. We also
observed that for every 100 grams increase in birth weight, the odds of
death decreased by 20% from the baseline risk (Table II).
This model as a whole had a sensitivity of 78%, specificity of 94%,
positive predictive value of 83%, negative predictive value of 93%, a
positive likelihood ratio of 13 and a negative likelihood ratio of 0.2.
The concordance statistic (c-statistic) of the model was 0.95 (95% CI
91.6-98.9; P<0.001).
TABLE II Multivariate Logistic Regression Model for Predicting Death in Neonates With Meconium Aspiration Syndrome
Variables |
β
coefficient |
Adjusted Odds ratio (95% CI) |
P value |
Birth weight (g) |
- 0.002 |
0.998 (0.997-1.00) |
0.005 |
Initial oxygen requirement (%) |
0.044 |
1.044 (1.02-1.07) |
<0.001 |
Myocardial dysfunction |
3.35 |
28.5 (8.0-101) |
<0.001 |
Note: For binomial independent variable (Myocardial
dysfunction) 0 (no event) was taken as reference category;
direction of the β coefficient
indicates the direction of the association |
Discussion
In this study on 170 neonates who developed MAS,
one-fourth died. About half of the neonates had HIE whereas a
significant number of neonates developed complications. Presence of
myocardial dysfunction and a higher initial oxygen requirement
independently increased the odds of mortality.
Previous studies have shown a wide range (5-40%) in
the mortality among infants with MAS with recent studies showing lower
(<15%) mortality rate [13-15]. A higher mortality rate observed in the
current study could be related to higher proportion of small for
gestational age (SGA) neonates. An association between intra-uterine
growth retardation (IUGR) and MAS has been described earlier [5]. The
emergence of myocardial dysfunction as an independent risk factor for
death indicates the major role of cardiovascular instability in
modifying the outcome in such neonates. This also emphasizes the need
for aggressive and close cardiovascular monitoring and early vascular
support in such neonates. Previous studies have observed PPHN,
pneumothorax, birth asphyxia, need for respiratory support in the first
48 hours of life and the need for vasopressor support as independent
predictors of mortality [5,15,16].
Our study has few limitations. First, PPHN and
myocardial dysfunction were diagnosed primarily on the basis of clinical
presentation, and were not always confirmed by echocardiography. Second,
MAS associated mortality (cause-specific) could not be separated out of
all-cause mortality due to the presence of various co-morbidities,
especially HIE.
To conclude, MAS is associated with significant
mortality during the hospital stay. Myocardial dysfunction and a higher
initial oxygen requirement increased the odds of death whereas a higher
birth weight decreases the odds of death.
Contributors: DL: Data collection and drafted the
manuscript; VS: designed the study, performed the analysis, helped in
drafting, and reviewed the manuscript; KM, SD and PK: supervised the
study and critically reviewed the manuscript.
Funding: None; Competing interests: None
stated.
What This Study Adds?
Meconium aspiration syndrome in neonates is
associated with high (26%) mortality.
Myocardial dysfunction and higher initial
oxygen requirement is associated with higher mortality whereas a
higher birth weight is associated with decreased mortality.
|
References
1. Ross MG. Meconium aspiration syndrome more than
intrapartum meconium. N Engl J Med. 2005;353:946-8
2. Locatelli A, Regalia AL, Patregnani C, Ratti M,
Toso L, Ghidini A. Prognostic value of change in amniotic fluid color
during labor. Fetal Diagn Ther. 2005;20:5-9
3. Qian L, Liu C, Zhuang W, Guo Y, Yu J, Chen H,
et al. Neonatal respiratory failure: a 12-month clinical epidemio-logic
study from 2004 to 2005 in China. Pediatrics. 2008;121:e1115-24
4. Malik AS, Hillman D. Meconium aspiration syndrome
and neonatal outcome in a developing country. Ann Trop Pediatr.
1994;14:47-51
5. Gupta V, Bhatia BD, Mishra OP. Meconium stained
amniotic fluid: antenatal, intrapartum and neonatal attributes. Indian
Pediatr. 1996;33:293-7
6. Bhat RY, Rao A. Meconium-stained amniotic fluid
and meconium aspiration syndrome: a prospective study. Ann Trop Pediatr.
2008;28:199-203
7. Kattwinkel J, Perlman JM, Aziz K, Colby C,
Fairchild K, Gallagher J, et al. Neonatal resuscitation: 2010
American Heart Association Guidelines for Cardiopulmonary Resuscitation
and Emergency Cardiovascular Care. Pediatrics. 2010;126:e1400-13.
8. Konduri GG. New approaches for persistent
pulmonary hypertension of newborn. Clin Perinatol. 2004;31:591-611.
9. Walsh MC, Stork EK. Persistent pulmonary
hypertension of the newborn. Rational therapy based on patho-physiology.
Clin Perinatol. 2001;28:609-27.
10. Zubrow AB, Hulman S, Kushner H, Falkner B.
Determinants of blood pressure in infants admitted to neonatal intensive
care units: a prospective multicenter study. Philadelphia Neonatal Blood
Pressure Study Group. J Perinatol. 1995;15:470-9.
11. Sarnat HB, Sarnat MS. Neonatal encephalopathy
following fetal distress. A clinical and electroencephalographic study.
Arch Neurol. 1976;33:696-705.
12. Levene ML, Kornberg J, Williams TH. The incidence
and severity of post-asphyxial encephalopathy in full-term infants.
Early Hum Dev. 1985;11:21-6.
13. Sriram S, Wall SN, Khoshnood B, Singh JK, Hsieh
HL, Lee KS. Racial disparity in meconium-stained amniotic fluid and
meconium aspiration syndrome in the United States, 1989-2000. Obstet
Gynecol. 2003;102:1262-8.
14. Wiswell TE, Tuggle JM, Turner BS. Meconium
aspiration syndrome: have we made a difference? Pediatrics.
1990;85:715-21.
15. Yoder BA, Kirsch EA, Barth WH, Gordon MC.
Changing obstetric practices associated with decreasing incidence of
meconium aspiration syndrome. Obstet Gynecol. 2002;99:731-9
16. Singh BS, Clark RH, Powers RJ, Spitzer AR.
Meconium aspiration syndrome remains a significant problem in the NICU:
outcomes and treatment patterns in term neonates admitted for intensive
care during a ten-year period. J Perinatol. 2009;29:497-503.
|
|
 |
|